These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4050499)

  • 21. [In unipolar depression does the response to the dexamethasone suppression test predict a symptomatic recurrence after clinical cure?].
    Charles G; Schittecatte M; Maes JM; Rush AJ; Wilmotte J
    Acta Psychiatr Belg; 1986; 86(3):249-56. PubMed ID: 3751648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible clinical applications of laboratory tests in depression.
    Fiori M; Davis KL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):6-11. PubMed ID: 6370977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dexamethasone suppression test and endogenous components of evoked potentials in depressed subjects].
    Pholien P; Charles G; Tilmant JJ; Wilmotte J
    Acta Psychiatr Belg; 1987; 87():694-703. PubMed ID: 3452988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dexamethasone test: suppressors and non-suppressors, what's the difference?].
    Vandel S; Bonin B; Vandel B; Allers G; Volmat R
    Encephale; 1985; 11(4):157-62. PubMed ID: 2935387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms.
    Reus VI
    Biol Psychiatry; 1982 Mar; 17(3):317-26. PubMed ID: 7082699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dexamethasone suppression test and unipolar-bipolar classification of depression].
    Ayuso Gutiérrez JL; García-Camba E; Cabranes JA; Almoguera MI
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985; 13(1):1-4. PubMed ID: 4025025
    [No Abstract]   [Full Text] [Related]  

  • 27. Vasopressin-neurophysin and DST in major depression: relationship with suicidal behavior.
    Pitchot W; Scantamburlo G; Pinto E; Hansenne M; Reggers J; Ansseau M; Legros JJ
    J Psychiatr Res; 2008 Jul; 42(8):684-8. PubMed ID: 17720191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Instability in the response to DST in major depressions during treatment with 5-hydroxytryptophan and carbidopa.
    Lopez-Ibor JJ; Saiz-Ruiz J; Perez de los Cobos JC
    Acta Psychiatr Belg; 1985; 85(3):450-8. PubMed ID: 3876688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
    Papadopoulos A; Ebrecht M; Roberts AD; Poon L; Rohleder N; Cleare AJ
    J Affect Disord; 2009 Jan; 112(1-3):289-94. PubMed ID: 18573538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U; Naor S; Asnis G; Gasparini F; Goldstein S; Vital-Herne J; Kang BJ
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract]   [Full Text] [Related]  

  • 33. Noradrenergic function and the cortisol response to dexamethasone in depression.
    Rubin AL; Price LH; Charney DS; Heninger GR
    Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dysfunction of the hypothalamic-pituitary-adrenal axis in adolescents after a suicide attempt].
    Gmitrowicz A; Kołodziej-Maciejewska H
    Psychiatr Pol; 2001; 35(5):803-18. PubMed ID: 11842612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypothalamic-pituitary-adrenal system in panic disorder.
    Goldstein S; Halbreich U; Asnis G; Endicott J; Alvir J
    Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD; Sullivan AC; Byrnes SM
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value and limits of conducting several neuro-endocrine tests in the diagnosis of depressive states].
    Schmitt L; Granier F; Girard M; Zarouk B; Escande M
    Ann Med Psychol (Paris); 1985 Feb; 143(2):166-74. PubMed ID: 3929664
    [No Abstract]   [Full Text] [Related]  

  • 39. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
    Beckwith BE; Parker L; Pawlarczyk D; Couk DI; Schumacher KS; Yearwood K
    Biol Psychiatry; 1985 Aug; 20(8):825-31. PubMed ID: 4027299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dexamethasone suppression test and response to somatic treatment: a review.
    Gitlin MJ; Gerner RH
    J Clin Psychiatry; 1986 Jan; 47(1):16-21. PubMed ID: 3510195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.